2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer
SAN FRANCISCO, and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma
SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Chula Researchers Culture "Global-Warming Resistant Corals" for the Survival of Marine Ecosystems
BANGKOK, May 26, 2025 /PRNewswire/ -- Researchers at Chulalongkorn University 's Aquatic Resources Research Institute have developed innovative methods to help corals adapt to global warming. Through artificial insemination and raising corals in...
Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.
AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody Drugs TOKYO, May 7, 2025 /PRNewswire/ -- Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as...
Agri-Tech Leader FAMSUN Leads Rapid Earthquake Recovery Efforts in Myanmar, Restoring Vital Feed Production
BANGKOK, April 12, 2025 /PRNewswire/ -- In the wake of the devastating 7.7-magnitude earthquake that struck Myanmar's Mandalay region on March 28, 2025, FAMSUN launched an urgent cross-border response to help restore animal feed production and...
Global Terrorism Index 2025: Terrorism Spreads as Lone Wolf Attacks Dominate the West
LONDON, March 5, 2025 /PRNewswire/ -- The number of countries recording a terrorist attack increased from 58 to 66, according to the 12th annual Global Terrorism Index (GTI) released today. This reverses nearly a decade of improvements, with 45...
DeepQure Advances Global Clinical Trials for Innovative RDN Technology
SEOUL, South Korea, March 4, 2025 /PRNewswire/ -- Breaking Barriers in Hypertension Treatment DeepQure Inc., a pioneering medical device startup, is revolutionizing the treatment of resistant hypertension with its innovative extravascular...
Turfan, Xinjiang: Electric Power to Transform 390,000 Mu of Grape Racks
TURFAN, China, Feb. 27, 2025 /PRNewswire/ -- On February 27, in the vineyard of Yuwangkel Village, Shanshan County, Turfan City, villagers were conducting grape rack transformations under the meticulous guidance of agricultural technicians. Adjacent...
TIER IV, Nihon Kotsu launch data collection project to enhance autonomous driving AI
TOKYO, Feb. 7, 2025 /PRNewswire/ -- TIER IV, the pioneering force behind the world's first open-source software for autonomous driving, and Nihon Kotsu, Tokyo's largest taxi company, launched a pioneering project in February to collect driving data...
GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy
SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ -- GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the development of GI-102 and ADC pancreatic cancer combination therapy. From...